SkinHealth Systems (NASDAQ:SKIN) received new United States Food and Drug Administration clearance for its specialized SkinStylus SteriLock MicroSystem to improve the appearance of periorbital wrinkles in adult patients.
Axsome Therapeutics (NASDAQ:AXSM) announced it dosed the first patient in its Phase 3 FOCUS-2 clinical trial evaluating solriamfetol as a potential treatment for children with attention deficit hyperactivity disorder.
Amazon.com (NASDAQ:AMZN) is looking to raise at least $25 billion through a U.S. dollar bond sale, according to Bloomberg News, as the company continues funding AI infrastructure investments.
Tvardi Therapeutics (NASDAQ:TVRD) reported Phase 1 data for TTI-109, a phosphate prodrug of STAT3 inhibitor TTI-101, including up to 60% reductions in STAT3-driven Th17, Tfh, and B cell populations.
XRP (CRYPTO:XRP) surpassed the key US$1.14 resistance level in recent trading sessions, marking a significant technical milestone after weeks of being capped below that threshold.
Walmart (NASDAQ:WMT) announced extensive price rollbacks on seasonal food items, including ground beef, sodas, and fresh produce to help consumers combat persistent grocery inflation pressures.
Lumen Technologies (NYSE:LUMN) completed its $475 million acquisition of Alkira, an on-demand networking platform that helps enterprises connect clouds, sites, partners, and AI workloads.
Samsung Electronics fell 6.92% in South Korea after forecasting a 19-fold jump in second-quarter operating profit to ₩89.4 trillion, pressuring chip stocks across global markets.
Kailera Therapeutics (NASDAQ:KLRA) reported topline data from two Jiangsu Hengrui Pharmaceuticals Phase 3 trials of oral GLP-1 agonist HRS-7535/KAI-7535 in China, including mean weight loss of up to 11.1%.
Arthur J Gallagher (NYSE:AJG) announced it has acquired retail insurance broker Wilson M Beck Insurance Services to expand its commercial service footprint across Western Canada.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
